Skip to main content
Table of Contents
Print

Could Cannabis Replace SSRIs or Lithium in Certain Cases of Mood Disorders? 

Author: Dr. Clarissa Morton, PharmD

The debate around cannabis vs SSRIs or mood stabilisers like lithium has grown as patients explore alternatives to traditional medication. While SSRIs and lithium remain gold standards in treating mood disorders, some individuals with a mental health condition  are curious about whether cannabis could serve as a substitute. Early research suggests cannabis may provide symptom relief, but evidence is not yet strong enough to recommend it as a replacement. 

Cannabinoids may play a role as adjuncts, but replacing antidepressants or mood stabilisers carries significant risks without robust clinical backing. 

Cannabis Compared with Traditional Medications 

When examining cannabis vs SSRIs, researchers often consider how cannabis interacts with the same pathways as conventional drugs while also exploring whether it could reduce dependency on them. 

Cannabis Vs Lithium 

The debate over cannabis vs lithium highlights contrasting mechanisms: lithium stabilises mood through long-term neurochemical regulation, while cannabis works more quickly but inconsistently, especially with high-THC strains. 

Cannabis As Alternative Treatment 

Some patients explore cannabis as an alternative treatment, particularly if they experience side effects from antidepressants. However, current evidence supports cannabis more as a complement than a full replacement. 

Replacing Antidepressants with Cannabis 

The concept of replacing antidepressants with cannabis remains speculative. Without large-scale clinical trials, cannabis cannot yet match the reliability and safety profile of SSRIs. 

In summary, while cannabis vs SSRIs comparisons show some promise, cannabis is not yet a proven substitute for standard treatments like SSRIs or lithium in mood disorders. 

For patients considering alternatives, providers like LeafEase can offer safe and professional consultations to explore personalised treatment pathways. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories